Myelodysplastic syndrome after autologous bone marrow transplantation: An additional late complication of curative cancer therapy

Keyphrases

• Myelodysplastic Syndrome 100%
• Cancer Therapy 100%
• Allogeneic Bone Marrow Transplantation 100%
• Late Complications 100%
• Non-Hodgkin Lymphoma 16%
• Pretransplant 16%
• Hodgkin Disease 16%
• University of Minnesota 8%
• Minneapolis 8%
• Chemotherapy Regimen 8%
• Lymphoma 8%
• Transplantation 8%
• Radiation Therapy 8%
• Chemotherapy 8%
• Statistical Analysis 8%
• Transplantation Therapy 8%
• Salvage Chemotherapy 8%
• Autologous Transplantation 8%
• Peripheral Blood Stem Cells 8%
• Antineoplastic Drugs 8%
• Confidence Interval 8%
• Secondary Acute Myeloid Leukemia (sAML) 8%
• Cumulative Incidence 8%
• Autopsy 8%
• Purging 8%
• Cytogenetic Abnormalities 8%
• Clonal Cytogenetic Abnormalities 8%
• Cytopenia 8%
• Additional Therapy 8%
• Sequential Lymphoma 8%
• Salvage Radiation 8%
• High Light Treatment 8%

Medicine and Dentistry

• Cancer Therapy 100%
• Myelodysplastic Syndrome 100%
• Autologous Bone Marrow Transplantation 100%
• Transplantation 25%
• Non-Hodgkin Lymphoma 16%
• Hodgkin's Lymphoma 16%
• Morphology 8%
• Chemotherapy 8%
• In Vitro 8%
• Acute Leukemia 8%
• Autotransplantation 8%
• Peripheral Blood Stem Cell 8%
• Conditioning 8%
• Cumulative Incidence 8%
• Cytopenia 8%
• Radiation Therapy 8%